SELLAS Life Sciences Group, Inc. Goodwill
SELLAS Life Sciences Group, Inc. (SLS) had Goodwill of $1.91 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2026-08-11
- 2026-06-30: Goodwill $1.91M.
- 2026-03-31: Goodwill $1.91M.
- 2025-12-31: Goodwill $1.91M.
- 2025-09-30: Goodwill $1.91M.
| Period end | Goodwill | Goodwill as first filed |
|---|---|---|
| 2026-06-30 | $1.91M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $1.91M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $1.91M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $1.91M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.91M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $1.91M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $1.91M 10-K · filed 2026-03-19 | |
| 2024-09-30 | $1.91M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.91M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.91M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $1.91M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $1.91M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.91M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.91M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.91M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $1.91M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.91M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.91M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.91M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $1.91M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.91M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.91M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.91M 10-K · filed 2023-03-16 | |
| 2020-09-30 | $1.91M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $1.91M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $1.91M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $1.91M 10-K · filed 2021-03-23 | |
| 2019-09-30 | $1.91M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.91M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $1.91M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $1.91M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $1.91M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $1.91M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $1.91M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $1.91M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $5.39M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $5.90M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $5.90M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $5.90M 10-Q · filed 2017-11-09 | |
| 2016-09-30 | $5.90M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $5.90M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $5.90M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $5.90M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $5.90M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $6.07M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $6.07M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $5.90M 10-K/A · filed 2016-04-15 | $6.07M 10-K · filed 2015-03-05 |
| 2014-09-30 | $5.90M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $5.90M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $5.90M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $5.90M 8-K · filed 2015-12-04 | |
| 2013-09-30 | $5.90M 10-Q/A · filed 2013-11-07 | |
| 2013-06-30 | $5.90M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $5.90M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $5.90M 10-K · filed 2014-03-17 | |
| 2012-09-30 | $5.90M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $5.90M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $5.90M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $5.90M 10-K · filed 2013-03-12 | |
| 2011-09-30 | $845.00K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $845.00K 10-Q/A · filed 2011-10-28 | |
| 2010-12-31 | $0.00 10-K · filed 2012-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |